Source:http://linkedlifedata.com/resource/pubmed/id/21375457
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-4-11
|
pubmed:abstractText |
Neointimal formation in atheromatous blood vessels is associated with both growth factor-induced differentiation of smooth muscle cells and endothelial-to-mesenchymal transition. Transforming growth factor beta (TGF?)-signaling is well known to play a critical role in the regulation of vessel remodeling as well as in atherosclerosis and restenosis. Here, we investigated the role of TGF?1 and N-cadherin on the differentiation and migration of human vascular smooth muscle cells (VSMC). TGF?1-treatment of cultured VSMC reduced their migratory activity as determined in cell migration assays. This reduced migration correlated with increased concentration of N-cadherin on mRNA and protein level. The TGF?1-induced increase of N-cadherin was sensitive against pharmacological inhibition of the ALK5 TGF? receptor and was accompanied by TGF?1-induced expression of the transcription factor snail1. Activation of N-cadherin by using a HAV-containing peptide of N-cadherin also decreased the migration of VSMC. N-cadherin-mediated suppression of VSMC migration was associated with an increased activity of RhoA, which is activated by binding of the HAV peptide to N-cadherin. Our results demonstrate that TGF?1 induces the differentiation of primary VSMC cells by Smad2/3-dependent up-regulation of the transcription factor snail1 and subsequently of N-cadherin, leading to inhibition of VSMC migration by RhoA-dependent modulation of the actin cytoskeleton.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1437-4315
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
392
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-74
|
pubmed:meshHeading |
pubmed-meshheading:21375457-Cadherins,
pubmed-meshheading:21375457-Cell Adhesion,
pubmed-meshheading:21375457-Cell Line,
pubmed-meshheading:21375457-Cell Movement,
pubmed-meshheading:21375457-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:21375457-Humans,
pubmed-meshheading:21375457-Immunohistochemistry,
pubmed-meshheading:21375457-Muscle, Smooth, Vascular,
pubmed-meshheading:21375457-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21375457-Transforming Growth Factor beta,
pubmed-meshheading:21375457-rho GTP-Binding Proteins
|
pubmed:year |
2011
|
pubmed:articleTitle |
TGF?1 suppresses vascular smooth muscle cell motility by expression of N-cadherin.
|
pubmed:affiliation |
Internal Medicine I, Nephrology, University of Ulm, Albert-Einstein-Allee, Germany.
|
pubmed:publicationType |
Journal Article
|